Abstract
Taurine is an abundant beta-amino acid found in high concentration in mammalian tissues. Taurine possesses many beneficial functions in mammalian cells. There are also a variety of taurine-conjugated products formed between taurine and bile acids, fatty acids, chloramine, mitochondrial tRNA, etc., and some of these have been identified as functional compounds. In the present study, we identified taurine-conjugated metabolites using LC–MS-based metabolome analysis of heart extracts prepared from hearts of wild-type and taurine transporter-knockout (TauTKO) mice, the latter being severely taurine deficient. Comparison analysis of metabolites identified taurine-containing dipeptides, including glutamyltaurine, aspartyltaurine, isoleucyltaurine, and leucyltaurine, which are present in wild-type but not TauTKO hearts. Acyltaurines (taurine-conjugated fatty acids) and taurine-conjugated bile acids were also detected, with levels unchanged in the TauTKO heart in comparison to the wild-type heart. These results demonstrate that taurine exists not only in the standard free form within the heart, but also in multiple conjugated forms, whose functions in the heart remain to be discovered.
This is a preview of subscription content, log in via an institution to check access.
References
Bittner S, Win T, Gupta R (2005) γ-l-glutamyltaurine. Amino Acids 28:343–356. doi:10.1007/s00726-005-0196-7
Board PG, Moore KA, Smith JE (1978) Purification and properties of gamma-glutamylcyclotransferase from human erythrocytes. Biochem J 173:427–431
Burg MB, Ferraris JD (2008) Intracellular organic osmolytes: function and regulation. J Biol Chem 283:7309–7313
Davies J, Evans RH, Jones AW et al (1982) Differential activation and blockade of excitatory amino acid receptors in the mammalian and amphibian central nervous systems. Comp Biochem Physiol C Comp Pharmacol 72:211–224
Franchi-Gazzola R, Gaccioli F, Bevilacqua E et al (2004) The synthesis of SNAT2 transporters is required for the hypertonic stimulation of system A transport activity. Biochim Biophys Acta Biomembr 1667:157–166. doi:10.1016/j.bbamem.2004.09.012
Hashioka S, Suzuki H, Nakajima D et al (2016) Metabolomics analysis implies noninvolvement of the kynurenine pathway neurotoxins in the interferon-gamma-induced neurotoxicity of adult human astrocytes. Neuropsychiatry (London) 7:610–617
Heller-Stilb B, van Roeyen C, Rascher K et al (2002) Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice. FASEB J 16:231–233. doi:10.1096/fj.01-0691fje
Ito T, Fujio Y, Hirata M et al (2004) Expression of taurine transporter is regulated through the TonE (tonicity-responsive element)/TonEBP (TonE-binding protein) pathway and contributes to cytoprotection in HepG2 cells. Biochem J 382:177–182. doi:10.1042/BJ20031838
Ito T, Kimura Y, Uozumi Y et al (2008) Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. J Mol Cell Cardiol 44:927–937. doi:10.1016/j.yjmcc.2008.03.001
Ito T, Yoshikawa N, Inui T et al (2014) Tissue depletion of taurine accelerates skeletal muscle senescence and leads to early death in mice. PLoS One. doi:10.1371/journal.pone.0107409
Ito T, Yoshikawa N, Ito H, Schaffer SW (2015) Impact of taurine depletion on glucose control and insulin secretion in mice. J Pharmacol Sci 129:59–64. doi:10.1016/j.jphs.2015.08.007
Jolliffe IT (1986) Principal component analysis. Springer, Newyork, pp 1–9
Jong CJ, Ito T, Prentice H et al (2017) Role of mitochondria and endoplasmic reticulum in taurine-deficiency-mediated apoptosis. Nutrients 9:1–17. doi:10.3390/nu9080795
Li YT, Maskos K, Chou CW et al (2003) Presence of an unusual GM2 derivative, taurine-conjugated GM2, in Tay-Sachs brain. J Biol Chem 278:35286–35291. doi:10.1074/jbc.M306126200
Liu A, Patterson AD, Yang Z et al (2009) Fenofibrate metabolism in the cynomolgus monkey using ultraperformance liquid chromatography-quadrupole time-of-flight mass spectrometry-based metabolomics. Drug Metab Dispos 37:1157–1163. doi:10.1124/dmd.108.025817
Marcinkiewicz J, Kontny E (2014) Taurine and inflammatory diseases. Amino Acids 46:7–20
Miyazaki T, Matsuzaki Y (2014) Taurine and liver diseases: a focus on the heterogeneous protective properties of taurine. Amino Acids 46:101–110
Pion PD, Kittleson MD, Rogers QR, Morris JG (1987) Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy. Science 237:764–768. doi:10.1126/science.3616607 (80−)
Saghatelian A, Trauger SA, Want EJ et al (2004) Assignment of endogenous substrates to enzymes by global metabolite profiling. Biochemistry 43:14332–14339. doi:10.1021/bi0480335
Saghatelian A, McKinney MK, Bandell M et al (2006) A FAAH-regulated class of N-acyl taurines that activates TRP ion channels. Biochemistry 45:9007–9015. doi:10.1021/bi0608008
Sakurai N, Ara T, Enomoto M, Motegi T, Morishita Y, Kurabayashi A, Iijima Y, Ogata Y, Nakajima D, Suzuki H, Shibata D (2014) Tools and databases of the KOMICS web portal for preprocessing, mining, and dissemination of metabolomics data. Biomed Res Int 2014:194812. doi:10.1155/2014/194812
Schaffer S, Takahashi K, Azuma J (2000) Role of osmoregulation in the actions of taurine. Amino Acids 19:527–546. doi:10.1007/s007260070004
Schaffer SW, Azuma J, Mozaffari M (2009) Role of antioxidant activity of taurine in diabetes. Can J Physiol Pharmacol 87:91–99. doi:10.1139/Y08-110
Schaffer SW, Shimada-Takaura K, Jong CJ et al (2016) Impaired energy metabolism of the taurine-deficient heart. Amino Acids 48:549–558. doi:10.1007/s00726-015-2110-2
Schaffer SW, Jong CJ, Ito T, Azuma J (2014) The other is "Role of taurine in the pathologies of MELAS and MERRF. Amino Acids 46(1):47–56. doi:10.1007/s00726-012-1414-8
Shi X, Yao D, Chen C (2012) Identification of N-acetyltaurine as a novel metabolite of ethanol through metabolomics-guided biochemical analysis. J Biol Chem 287:6336–6349. doi:10.1074/jbc.M111.312199
Stryer L (1995) Biochemistry, 4th edn. W. H, Freeman and Company, New York
Taylor J, King RD, Altmann T, Fiehn O (2002) Application of metabolomics to plant genotype discrimination using statistics and machine learning. Bioinformatics 18(Suppl 2):S241–S248. doi:10.1093/BIOINFORMATICS/18.SUPPL_2.S241
Trama J, Go WY, Ho SN (2002) The osmoprotective function of the NFAT5 transcription factor in T cell development and activation. J Immunol 169:5477–5488. doi:10.4049/jimmunol.169.10.5477
Uemura S, Ienaga K, Higashiura K, Kimura H (1992) ??-Glutamyltaurine has potent and long-lasting antiepileptic action as demonstrated by intra-amygdaloid injection in amygdala-kindled rats. Brain Res 594:347–350. doi:10.1016/0006-8993(92)91150-D
Warskulat U, Flögel U, Jacoby C et al (2004) Taurine transporter knockout depletes muscle taurine levels and results in severe skeletal muscle impairment but leaves cardiac function uncompromised. FASEB J 18:577–579. doi:10.1096/fj.03-0496fje
Warskulat U, Borsch E, Reinehr R et al (2006) Chronic liver disease is triggered by taurine transporter knockout in the mouse. FASEB J 20:574–576. doi:10.1096/fj.05-5016fje
Worley B, Powers R (2012) Multivariate analysis in metabolomics. Curr Metab 1:92–107. doi:10.2174/2213235X11301010092
Xia J, Wishart DS (2016) Using MetaboAnalyst 3.0 for comprehensive metabolomics data analysis. Curr Protoc Bioinf 55:14.10.1–14.10.91
Acknowledgements
The authors thank Shinichi Ueno (Hyogo University of Health Sciences) for animal care and Chisato Kotani (Kazusa DNA Research Institute) for data analysis. This work is supported from the JSPS KAKENHI Grant Numbers 22790097 and 25750368.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
“All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.”
Rights and permissions
About this article
Cite this article
Ito, T., Okazaki, K., Nakajima, D. et al. Mass spectrometry-based metabolomics to identify taurine-modified metabolites in heart. Amino Acids 50, 117–124 (2018). https://doi.org/10.1007/s00726-017-2498-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-017-2498-y